| Mrs April Yoder, | |
|
910 N College Ave Ste 4, Columbia, MO 65201-4797 | |
| (636) 642-1215 | |
| Not Available |
| Full Name | Mrs April Yoder |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Location | 910 N College Ave Ste 4, Columbia, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932706298 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 2020033673 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs April Yoder, 910 N College Ave Ste 4, Columbia, MO 65201-4797 Ph: (636) 642-1215 | Mrs April Yoder, 910 N College Ave Ste 4, Columbia, MO 65201-4797 Ph: (636) 642-1215 |
News Archive
Tremelimumab, one of a new class of immunomodulatory monoclonal antibodies, has shown encouraging clinical activity and acceptable tolerability in patients with chemotherapy-resistant malignant mesothelioma, results of a single-arm phase II study show.
The National Institute of Allergy and Infectious Diseases has awarded the Perelman School of Medicine at the University of Pennsylvania a five-year, $10 million renewal of a program project to study the oldest part of the human immune system called the complement system, or simply "complement."
The global diagnostics industry has witnessed strong growth over the past few years. According to Frost & Sullivan, the diagnostics and monitoring sectors are poised to present more growth opportunities. According to Nitin Naik, Vice President of Frost & Sullivan's Asia Pacific Medical Technologies Division, the diagnostics and monitoring sectors in Asia Pacific are projected to provide more growth opportunities on the basis of the technology spending being channelled in these areas (80 percent).
The U.S. Food and Drug Administration (FDA) has issued warnings for doctors, hospitals and clinics regarding contaminated ultrasound gel produced by a New Jersey company that infected 16 cardiac patients and could pose serious risks to pregnant women and others who undergo ultrasound imaging and treatment.
ViroPharma Incorporated today announced that it has completed enrollment in its Phase 2 study evaluating subcutaneous delivery of Cinryze™ (C1esterase inhibitor [human]). This multi-center, open-label, multi-dose Phase 2 study is designed to evaluate the safety, pharmacokinetics and pharmacodynamics of subcutaneous versus intravenous administration of Cinryze in adolescent and adult subjects with hereditary angioedema (HAE).
› Verified 6 days ago
Dr. Amber Michelle Oros, D.O., M.S. General Practice Medicare: Medicare Enrolled Practice Location: 1 Hospital Dr Ste M562, Columbia, MO 65212 Phone: 573-884-3233 | |
Pavel Svintozelsky, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 200 Corporate Lake Dr, Columbia, MO 65203 Phone: 573-814-1170 | |
Samuel Holt Mcnair, MD General Practice Medicare: Medicare Enrolled Practice Location: 1 Hospital Dr # Dc0.3200, Columbia, MO 65212 Phone: 573-864-8560 | |
Dr. Robert Calaluce, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 140 Walter Williams Hall, Columbia, MO 65211 Phone: 573-882-4204 Fax: 573-882-4204 | |
Dr. Siddharth Jain, D.O. General Practice Medicare: Medicare Enrolled Practice Location: 619 N Providence Rd, Columbia, MO 65203 Phone: 573-234-1070 Fax: 573-818-1342 | |
Dr. Bilel Amor, MD, AP General Practice Medicare: Not Enrolled in Medicare Practice Location: 400 N Keene St, Columbia, MO 65201 Phone: 573-882-4438 Fax: 573-884-9992 | |
Dr. William Mitchel See, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 2003 West Broadway Suite 100, Broadway Urgent Care, Columbia, MO 65202 Phone: 573-777-5880 Fax: 573-777-5875 |